
Priceline Pharmacy owner Australian Pharmaceutical Industries (API) has rejected a takeover offer from Wesfarmers.
API on Thursday said the $687 million offer for all shares, made earlier this month, undervalued the company.
The API board said it assessed medium and long-term growth prospects and decided the bid was opportunistic given the impact of COVID-19 on financial performance.
As well as Priceline, the business also owns the Soul Pattinson and Pharmacist Advice chemists, and Clear Skincare clinics.
Wesfarmers, which owns Bunnings and Officeworks, offered $1.38 per share.
Washington H Soul Pattinson, which owns 19.3 per cent of Australian Pharmaceutical Industries shares, was in favour of the offer.
API shares were higher by 1.06 per cent to $1.42 at 1119 AEST.
Wesfarmers shares were down by 0.54 per cent to $61.22.